Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
38 hedge funds and large institutions have $152M invested in Renalytix plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.
600% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 3
386% more call options, than puts
Call options by funds: $2.85M | Put options by funds: $587K
96% more capital invested
Capital invested by funds: $77.6M → $152M (+$74.7M)
90% more funds holding
Funds holding: 20 → 38 (+18)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$11.8M |
| 2 |
FAM
Fred Alger Management
New York
|
+$8.47M |
| 3 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$4.03M |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
+$2.77M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$6.07M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$902K |
| 3 |
Millennium Management
New York
|
-$799K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$367K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$273K |
RNLX Hedge Fund Activity: Q1 2021 in Review
38 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q1 2021, worth a combined $152M — up 96% from $77.6M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new RNLX positions and 3 closed out — a net gain of 18 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $11.8M. The largest seller was Parian Global Management, cutting an estimated $6.07M.
- 38 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q1 2021, up from 20 in Q4 2020.
- Funds reported $152M of Renalytix plc American Depositary Shares stock for Q1 2021, up 96% quarter-over-quarter.
- 21 funds opened new Renalytix plc American Depositary Shares positions in Q1 2021 and 3 closed out, a net change of +18 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q1 2021 was Gilder Gagnon Howe & Co, an estimated $11.8M added.
- The largest Renalytix plc American Depositary Shares seller in Q1 2021 was Parian Global Management, an estimated $6.07M sold.
Based on aggregated 13F filings for Q1 2021.